Novavax expands in Maryland as it gears up for late-stage COVID vaccine trial in the U.S.

Novavax has spent much of 2020 advancing its COVID-19 vaccine candidate through early-stage testing and preparing for manufacturing and distribution. And thanks to the promise of that vaccine and a separate flu program, the company is expanding its Maryland campus.